January 2016

Editorial Board
Published in issue: January 2016
e1

Committees
Published in issue: January 2016
e2

Sunday, 6th December 2015

Oral Poster Session 1

An unexpected higher prevalence of Parkinson's disease in females than males in the province of Trento (Italy): a clues for the etiopathogenesis?
• Maria Chiara Malaguti,
• Nicola Vanacore,
• Stefania Ferrari,
• ...
• Vincenzo Bertozzi,
• Maria Pellegrini,
• Daniele Orrico
Published in issue: January 2016
e3

Parkinson’s disease in Senegal: epidemiologic, clinical and therapeutic aspects
• Ndiaga Matar Gaye,
• Lala Bouna Seck,
• Ngor Side Diagne,
• ...
• Moustapha Ndiaye,
• Amadou Gallo Diop,
• Mouhamadou Mansour Ndiaye
Published in issue: January 2016
e3

Longer duration of Parkinson's disease is associated with reduced prevalence of hypertension
• Vincenzo Brandi,
• Davide Vetrano,
• Maria Stella Pisciotta,
• ...
• Graziano Onder,
• Roberto Bernabei,
• Giuseppe Zuccalà
Published in issue: January 2016
e3

Gastroesophageal dysmotility in advanced Parkinson’s disease
• Francesca Mancini,
• Luigi Manfredi,
• Marco Lacerenza,
• Carlotta Colombo,
• Alberto Bestetti
Published in issue: January 2016
e4

Speech disorders and Parkinson’s disease
• Massimo Pettorino,
• Elisa Pellegrino,
• Maria Grazia Busà
Published in issue: January 2016
e4


An alternative perspective on interpretation of the secondary motor symptoms of Parkinson disease
• Ludmila Vucolova
Published in issue: January 2016
e4-e5


An alternative perspective on interpretation of the cardinal motor symptoms of Parkinson disease
• Ludmila Vucolova
Published in issue: January 2016
e5

Falling direction is important predictors for mechanism of falls in patients with Parkinson’s disease
• Jinyoung Youn,
• Minho Hwang,
• Dongyeop Kim,
• Jin Whan Cho
Published in issue: January 2016
e5

Frequency and risk of falls in Parkinson’s disease in Ibadan
• Temitope Farombi,
• Mayowa Owolabi,
• Adesola Ogunniyi
Published in issue: January 2016
e5-e6

Falls in Parkinson's disease: Effects on health related quality of life
• Temitope Farombi,
• Joseph Yaria,
• Mayowa Owolabi,
• Adesola Ogunniyi
Published in issue: January 2016
e6


Oral Poster Session 2

A prospective study of cumulative incidence and course of RLS in de novo PD patients during chronic dopaminergic therapy
• Stefano Calzetti,
• Elena Marchesi,
• Matteo Goldoni,
• Anna Negrotti
Published in issue: January 2016
e7

Semantic and phonemic verbal fluency in patients with Parkinson's disease (PD)
• Anne Dorothée Roesch,
• Antonia Meyer,
• Karolina Nowak,
• Ute Gschwandtner,
• Peter Fuhr
Published in issue: January 2016
e7

Emotion recognition and emotion expression in Parkinson's disease: An unifying emotional mirror mechanism?
• Lucia Ricciardi,
• Federica Visco-Comandini,
• Roberto Erro,
• ...
• Diego Ricciardi,
• Mark Edwards,
• James Kilner
Published in issue: January 2016
e7

Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease
• Maria Stella Pisciotta,
• Davide Liborio Vetrano,
• Vincenzo Brandi,
• ...
• Graziano Onder,
• Roberto Bernabei,
• Giuseppe Zuccalà
Published in issue: January 2016
e8

Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson's disease patients
• Jose Santiago,
• Judith Potashkin
Published in issue: January 2016
e8

Impact of gender on impulse control disorders and other non-motor symptoms among Parkinson's disease patients
• Norbert Kovács,
• Gebriella Deli,
• Zsuzsanna Aschermann,
• Attila Makkos,
• József Janszky,
• Márton Kovács
Published in issue: January 2016
e8

Effects of Parkinson's disease on cognitive action control: Insights on impulsive response tendencies using an oculomotor Simon task
• Joan Duprez,
• Jean-François Houvenaghel,
• Soizic Argaud,
• Marc Vérin,
• Paul Sauleau
Published in issue: January 2016
e8-e9

Sensory attenuation and Parkinson's disease: A new pathophysiological framework of bradykinesia
• Antonella Macerollo,
• Jui-Cheng Chen,
• Prasad Korlipara,
• ...
• John Rothwell,
• Mark Edwards,
• James Kilner
Published in issue: January 2016
e9

Fine motor function skills in patients with Parkinson disease (PD) with and without mild cognitive impairment (MCI)
• Philippe Dahdal,
• Antonia Meyer,
• Menorca Chaturvedi,
• ...
• Anne Dorothée Roesch,
• Ute Gschwandtner,
• Peter Fuhr
Published in issue: January 2016
e9

Is decreased hand dexterity a reason for poor oral hygiene in Parkinson's disease?
• Fawaz Pullishery
Published in issue: January 2016
e9

Continuous monitoring of PD with an affordable novel computerised motor test based on a tablet
• Mauro Da Lio,
• Mariolino De Cecco,
• Paolo Bosetti,
• Mariachiara Malaguti
Published in issue: January 2016
e9-e10

Monday, 7th December 2015

Oral Poster Session 1

Relationship between Stay-at-home Patients' Understanding of Information regarding their Parkinson's Disease and the Burden of Spouse Caregivers
• Hisashi Takamoto,
• Masashi Hori
Published in issue: January 2016
e11


Restoration of Tensegrity Equilibrium Can Lead to Beneficial Modification of Parkinson Disease's Motor Symptoms
• Ludmila Vucolova
Published in issue: January 2016
e11

Use of three-dimensional gait analysis to assess the effectiveness of conventional rehabilitation protocols in people with Parkinson's disease
• Massimiliano Pau,
• Federica Corona,
• Carlo Casula,
• Roberta Pili,
• Mauro Murgia,
• Marco Guicciardi
Published in issue: January 2016
e12


The worse is the clinical status of the patient with Parkinson, the higher is the stride length percentage of improvement after Automated Mechanical Peripheral Stimulation.
• Ana Kleiner,
• Manuela Galli,
• Maria Gaglione,
• ...
• Giorgio Albertini,
• Fabrizio Stocchi,
• Maria Francesca De Pandis
Published in issue: January 2016
e12

Stress Reduction Training in PD Patients – Influence on neuropsychiatric symptoms?
• Antonia Meyer,
• Anousha Hadinia,
• Karolina Nowak,
• Ute Gschwandtner,
• Peter Fuhr
Published in issue: January 2016
e12

Cognitive Behavioral Group Therapy (CBT) for stress reduction in patients with Parkinson's disease – a randomized control trial
• Anousha Hadinia,
• Antonia Meyer,
• Karolina Nowak,
• Ute Gschwandtner,
• Peter Fuhr
Published in issue: January 2016
e12-e13

Quality of life measured by PDQ39 and SEIQoL during anti-stress training for Parkinson's disease (PD) patients
• Karolina Nowak,
• Antonia Meyer,
• Menorca Chaturvedi,
• Anousha Hadinia,
• Ute Gschwandtner,
• Peter Fuhr
Published in issue: January 2016
e13


Cortisol measurements as a laboratory biomarker for stress reduction in Parkinson's disease (PD) patients
• Karolina Nowak,
• Antonia Meyer,
• Anousha Hadinia,
• ...
• Anne Dorothée Roesch,
• Ute Gschwandtner,
• Peter Fuhr
Published in issue: January 2016
e13


Effects of Cognitive Loading on Standing Balance and Postural Stability in Parkinson's Disease Patients with Freezing of Gait
• Wannipat Buated,
• Praween Lolekha,
• Tsutomu Fujinami,
• Shohei Hidaka,
• Neeraj Kashyap
Published in issue: January 2016
e13-e14

Theatre is a valid complementary therapeutic intervention for emotional rehabilitation in Parkinson's disease patients
• Giovanni Mirabella,
• Paolo De Vita,
• Silvia Rampelli,
• ...
• Marco Grano,
• Sara Lubrani,
• Nicola Modugno
Published in issue: January 2016
e14


Pharmaceutical Design in Parkinson's Disease: What Do Patients Prefer?
• Kelly Lefteri,
• Fang Liu,
• Marc Brown
Published in issue: January 2016
e15

An insight from the ayurvedic perspective of neurodegeneration
• Jibin Joy
Published in issue: January 2016
e15


Oral Poster Session 2

Pharmacogenetics of levodopa: An algorithm for dose prediction
• Vivian Altmann,
• Mariana Rieck,
• Artur Schumacher-Schuh,
• Sídia Callegari-Jacques,
• Carlos de Mello Rieder,
• Mara Hutz
Published in issue: January 2016
e16

Treatment with l-dopa normalize learning as measured with CVLT-2 in drug naive patients with Parkinson’s disease
• Hilde Therese Johansen Sari,
• Ole- Bjørn Tysnes,
• Jan Petter Larsen,
• Arne Gramstad,
• Geir Olve Skeie
Published in issue: January 2016
e16

Onset and duration of motor effects with IPX066, levodopa-carbidopa extended-release capsules: Comparison with immediate-release levodopa-carbidopa and with levodopa-carbidopa+entacapone
• Suneel Gupta,
• Sarita Khanna,
• Robert Rubens,
• Nishit Modi
Published in issue: January 2016
e16

Outpatient levodopa-carbidopa intestinal gel titration in patients with advanced Parkinson's disease
• Ramon Rodriguez,
• Michael Lobatz,
• Jordan Dubow,
• ...
• Coleen Hall,
• Krai Chatamra,
• Janet Benesh
Published in issue: January 2016
e17


Effects of levodopa-carbidopa intestinal gel on non-motor symptoms and safety of outpatient titration: A new phase 3 study in patients with advanced Parkinson's disease
• David Standaert,
• John Slevin,
• Coleen Hall,
• ...
• Susan Eaton,
• Krai Chatamra,
• Janet Benesh
Published in issue: January 2016
e17-e18

Determination of minimal important difference thresholds for Parkinson’s disease Questionnaire-39 in advanced Parkinson’s disease patients
• Angelo Antonini,
• Elizabeth Dansie Bacci,
• Kavita Sail,
• ...
• Krai Chatamra,
• Ingela Wiklund,
• Dennis Revicki
Published in issue: January 2016
e18-e19

Gastrointestinal safety of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients: GLORIA long-term registry interim results
• Dirk Domagk,
• Sanne Dam-Larsen,
• Angelo Antonini,
• Lars Bergmann,
• Ashley Yegin,
• Werner Poewe
Published in issue: January 2016
e19


Comparison of the antiparkinsonian and antidyskinetic effects of hemantane and amantadine
• Elena Ivanova,
• Inga Kapitsa,
• Elena Valdman,
• Tatyana Voronina
Published in issue: January 2016
e19-e20

Istradefylline Parkinson's disease trial: Methodology of data quality
• Marc Cantillon,
• George Wilson,
• Judy Montero,
• Barbara Novak,
• Robert Smith
Published in issue: January 2016
e20


A study of real life tolerability of rotigotine transdermal patch in Parkinson’s disease across all motor stages
• Rui Barreto,
• Anna Sauerbier,
• Alexandra Rizos,
• Ray Chaudhuri
Published in issue: January 2016
e20


Oral Poster Session 3

Rotigotine efficacy on sleep disturbances in Parkinson's disease patients: Evidence from a polysomnographic study
• Claudio Liguori,
• Mariangela Pierantozzi,
• Fabio Placidi,
• Alessandro Stefani
Published in issue: January 2016
e21

Efficacy of sublingual apomorphine (APL-130277) for the treatment of off episodes in patients with Parkinson's disease
• Albert Agro,
• Jordan Dubow,
• Bruce Dzyngel,
• ...
• Anthony Giovinazzo,
• Holly Shill,
• Robert Hauser
Published in issue: January 2016
e21


Baseline disease severity not predictive of sublingual apomorphine (APL-130277) dose needed to convert a PD patient from the off to on state
• Jordan Dubow,
• Bruce Dzyngel,
• Thierry Bilbault,
• Anthony Giovinazzo,
• Albert Agro
Published in issue: January 2016
e21-e22

Minimum MDS-UPDRS part III change needed to convert a Parkinson's disease patient from the off to full on state with sublingual apomorphine (APL-130277)
• Jordan Dubow,
• Bruce Dzyngel,
• Thierry Bilbault,
• Anthony Giovinazzo,
• Albert Agro
Published in issue: January 2016
e22

Differences between apomorphine (APO) and lisuride (LIS) in PD therapy
• Reinhard Horowski
Published in issue: January 2016
e22